What is Krystal Biotech, Inc. Common Stock's Market Cap?

Krystal Biotech, Inc. Common Stock's Market Cap is $9.2B, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's Enterprise Value?

Krystal Biotech, Inc. Common Stock's Enterprise Value is $8.8B, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's Trailing P/E?

Krystal Biotech, Inc. Common Stock's Trailing P/E is 38.2×, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's Price / Sales?

Krystal Biotech, Inc. Common Stock's Price / Sales is 20.9×, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's EV / Revenue?

Krystal Biotech, Inc. Common Stock's EV / Revenue is 20.0×, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's EV / EBITDA?

Krystal Biotech, Inc. Common Stock's EV / EBITDA is 44.4×, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's Revenue (TTM)?

Krystal Biotech, Inc. Common Stock's Revenue (TTM) is $440.5M, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's Net Income (TTM)?

Krystal Biotech, Inc. Common Stock's Net Income (TTM) is $241.5M, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's EBITDA?

Krystal Biotech, Inc. Common Stock's EBITDA is $203.6M, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's Diluted EPS (TTM)?

Krystal Biotech, Inc. Common Stock's Diluted EPS (TTM) is 8.16, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Krystal Biotech, Inc. Common Stock

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00HDGRHJ5

311.50▼ 8.63 (-2.70%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 320.13
Day's Range: 310.56 – 318.91
52-Week Range: 183.03 – 382.54
Volume: 247.8K
Avg Volume: 287.5K

Share Statistics

Shares Outstanding
Employees: 295
Exchange: XNAS
Listed: 2017-09-20

Share count as of July 28, 2026

Krystal Biotech, Inc. Common Stock (KRYS) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Krystal Biotech, Inc. Common Stock (KRYS)

What is Krystal Biotech, Inc. Common Stock's Market Cap?: Krystal Biotech, Inc. Common Stock's Market Cap is $9.2B, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's Enterprise Value?: Krystal Biotech, Inc. Common Stock's Enterprise Value is $8.8B, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's Trailing P/E?: Krystal Biotech, Inc. Common Stock's Trailing P/E is 38.2×, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's Price / Sales?: Krystal Biotech, Inc. Common Stock's Price / Sales is 20.9×, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's EV / Revenue?: Krystal Biotech, Inc. Common Stock's EV / Revenue is 20.0×, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's EV / EBITDA?: Krystal Biotech, Inc. Common Stock's EV / EBITDA is 44.4×, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's Revenue (TTM)?: Krystal Biotech, Inc. Common Stock's Revenue (TTM) is $440.5M, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's Net Income (TTM)?: Krystal Biotech, Inc. Common Stock's Net Income (TTM) is $241.5M, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's EBITDA?: Krystal Biotech, Inc. Common Stock's EBITDA is $203.6M, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's Diluted EPS (TTM)?: Krystal Biotech, Inc. Common Stock's Diluted EPS (TTM) is 8.16, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · KRYSAs-filed SEC (XBRL) data